pocketful logo light
pocketful logo light
Norris Medicines Ltd logo

Norris Medicines Ltd

NSE: BSE: 524414

₹15.22

(4.97%)

Tue, 15 Sept 2026, 02:27 am

mtf coin illustrationMTF 5x

Norris Medicines Share Price Live Chart

1 Day

(4.97%)

No Result Found

Summary

  • Market Cap (in Cr)

    13.25

  • Net Profit (in Cr)

    -1.24

  • P/B

    -1.12

  • Sector P/E

    44.89

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    0

  • ROCE

    0

  • Debt/Equity

    0

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    -15.82

  • Interest Cover

    -1.68

Analysis

No Result Found

Read More

Financials

No Result Found

Read More

Ratios

No Result Found

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters34.0134.0034.0034.0034.00
FII00000
DII0.070.070.070.070.07
Public65.9265.9365.9365.9365.93
Government00000

Read More

Technical Analysis

RSI

51.57

MACD

-0.22

50 DMA

15.59

200 DMA

14.65

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic21.8718.5716.7815.2713.4811.978.67
Fibonacci18.5717.3116.5315.2714.0113.2311.97
Camarilla15.9115.6115.3015.2714.7014.3914.09

Pivots Level: Classic

R3

+6.60

21.87

R2

+3.30

18.57

R1

+1.52

16.78

15.27
15.27
Pivot Point
LTP: 15.22

S1

-1.78

13.48

S2

-3.30

11.97

S3

-6.60

8.67

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    14.76

  • 20-EMA

    14.94

  • 30-EMA

    15.05

  • 50-EMA

    15.07

  • 100-EMA

    14.93

  • 200-EMA

    15.07

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 May 2026board-meetingsAccounts
14 Feb 2026board-meetingsQuarterly Results
14 Nov 2025board-meetingsQuarterly Results
01 Sept 2025agm
06 Sept 2024agm
29 Dec 2023egm
18 Nov 2023agm
09 Sept 2022agm
28 Aug 2021agm

Read More

Peer Comparison

No Result Found

Norris Medicines Ltd logo

Norris Medicines Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Norris Medicines Ltd About

Norris Medicines manufactures generic pharmaceutical tablets, capsules, syrups, and suspension form products. The Company produces a range of antibiotic, anti-inflammatory, and analgesic products, as well as products for nutrition, anxiety, diabetes, and

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1990

Headquarters

CEO

Vimal D Shah

Employees

Contact

Website icon

Website

http://www.norrispharma.com

Email icon

Email

norrismedicines@gmail.com; contact@norrispharma.co

Phone icon

Phone

91-2646-223462/227530

Location icon

Location

Plot No 801/P & 802, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002

Read More

Norris Medicines Ltd Company History

YearHistory
2000
  • The company issued 1,80,00,000 equity shares on a preferential/private placement basis to PHC Holdings Ltd. and Positive Healthcare (Asia) Ltd.
2006
  • The company launched diabetic and cardiac products.
2007
  • The company launched a dental product range.
2012
  • The company launched a new molecule Tolperisone with Paracetamol tablet.
2013
  • The company extended its anti-malarial range with Artemether Lumefantrine tablet and dry syrup.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
No Result Found

Read More

Norris Medicines Ltd News

Norris Medicines Appoints Iqubal Ismail Patel as CFO

Norris Medicines Limited has appointed Iqubal Ismail Patel as Chief Financial Officer and Key Managerial Personnel effective July 30, 2026. Patel brings over 11 years of internal experience in finance and corporate management to the role.

30 Jul 2026

companies

Norris Medicines board meeting on May 30

Norris Medicines Limited will hold a board meeting on May 30, 2026, to approve audited financial results for FY26. The trading window remains closed until 48 hours after the results declaration.

25 May 2026

companies

Norris Medicines Announces Q3 FY26 Results

Norris Medicines Limited's Board approved unaudited financial results for the quarter and year ended December 31, 2025, following their February 14, 2026 board meeting.

14 Feb 2026

co actions results

Norris Medicines Independent Director Resigns

Norris Medicines Limited announces resignation of Independent Director Ms. Sathya Venkatachalam effective December 12, 2025, citing personal reasons.

12 Dec 2025

stocks

Norris Medicines Clears NAFDAC Audit in Nigeria

Norris Medicines Limited successfully completed regulatory audit by Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) on December 9, 2025, with no critical observations reported.

12 Dec 2025

stocks

Read More

Frequently Asked Questions

  • 1.What is the stock price of Norris Medicines Ltd?

    As of 15/09/2026 at 7:57 AM, Norris Medicines Ltd shares are trading at ₹15.22.

  • 2.When was Norris Medicines Ltd founded?

    Norris Medicines Ltd was founded in 1990.

  • 3.How can I buy shares of Norris Medicines Ltd?

    You can buy shares of Norris Medicines Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 4.Does Norris Medicines Ltd pay dividends?

    No, Norris Medicines Ltd does not pay dividends to eligible shareholders currently.

  • 5.Who is the CEO of Norris Medicines Ltd?

    The CEO of Norris Medicines Ltd is Vimal D Shah.

Open Your Free Demat Account

Enter your phone number